https://www.selleckchem.com/pr....oducts/l-kynurenine.
Background In patients with coronary in-stent restenosis (ISR) requiring reintervention, it is unclear if the choice of treatment should depend on whether the restenotic stent was a bare-metal stent (BMS) or a drug-eluting stent (DES). Objectives This study aimed to assess the comparative efficacy and safety of the 2 most frequently used treatments - angioplasty with drug-coated balloon (DC and repeat stenting DES - in patients with BMS-and DES-ISR. Methods The DAEDALUS (Difference in Antirestenotic Effectiveness of Drug-Eluting
Like
Comment
Share
